“…Consequently, patients with N-1 often complain of (in addition to cataplexy) disrupted sleep/wake continuity and often display abnormal sleep architecture upon laboratory study. For example, several studies have shown that, compared to controls, N-1 is associated with reduced sleep efficiency, increased wake after sleep onset (WASO), high arousal indices, frequent sleep stage transitions, increased time in “light” sleep (Sorensen et al, 2013, Pizza et al, 2015, Mukai et al, 2003, Khatami et al, 2008, Jiménez-Correa et al, 2009, Frauscher et al, 2011; Roth et al, 2013) and abnormal REM sequencing (Liu et al, 2015, Drakatos et al, 2016). It is also well-documented that N-1 patients have a shortened latency to nocturnal REM, now known to be statistically specific for low or absent hypocretin (Andlauer et al, 2013, Reiter et al, 2015; Cairns and Bogan, 2015).…”